Related Experiment Video
Updated: May 23, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
Redefining hormone sensitive disease in advanced prostate cancer
1Division of Medical Oncology, University of Colorado Denver School of Medicine, 12801 E. 17th Avenue, Room L18-8117, Aurora, CO 80045, USA.
New prostate cancer therapies offer survival benefits and may reverse resistance to hormonal treatments, improving long-term management for advanced prostate cancer patients.
Area of Science:
- Oncology
- Urology
- Endocrinology
Background:
- Prostate cancer is the most prevalent cancer in US men.
- Androgen Deprivation Therapy (ADT), a hormonal therapy lowering testosterone, has been the standard for advanced prostate cancer.
- Castration-resistant prostate cancer (CRPC) development is a major obstacle in long-term patient management.
Purpose of the Study:
- To review recent advancements in medical therapies for prostate cancer.
- To evaluate the potential of new agents in overcoming hormonal resistance.
- To explore how these advancements redefine hormonally sensitive disease management.
Main Methods:
- Review of current medical literature on prostate cancer therapies.
- Analysis of clinical trial data for novel therapeutic agents.
- Synthesis of information on treatment outcomes and resistance mechanisms.
Main Results:
- New therapeutic agents have been developed for advanced prostate cancer.
- These agents demonstrate a survival benefit for patients.
- Emerging evidence suggests these therapies can reverse hormonal resistance in metastatic CRPC.
Conclusions:
- Advancements in medical therapy are expanding treatment options for advanced prostate cancer.
- New agents show promise in overcoming castration resistance.
- These developments may redefine the management of hormonally sensitive and resistant prostate cancer.
More Related Videos
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...